FRESENIUS KABI USA FDA Approval ANDA 071202

ANDA 071202

FRESENIUS KABI USA

FDA Drug Application

Application #071202

Application Sponsors

ANDA 071202FRESENIUS KABI USA

Marketing Status

Discontinued001

Application Products

001INJECTABLE;SPINAL0.75%0SENSORCAINEBUPIVACAINE HYDROCHLORIDE

FDA Submissions

ORIG1AP1987-04-15
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1992-09-11
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1996-06-26
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1995-08-29
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1996-04-17
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1996-05-31
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1997-04-14
MANUF (CMC); Manufacturing (CMC)SUPPL9AP2002-12-23
LABELING; LabelingSUPPL10AP2005-07-21
LABELING; LabelingSUPPL12AP2010-06-14
MANUF (CMC); Manufacturing (CMC)SUPPL14AP2012-06-30
LABELING; LabelingSUPPL16AP2012-12-11STANDARD

Submissions Property Types

SUPPL2Null0
SUPPL3Null0
SUPPL4Null0
SUPPL5Null0
SUPPL7Null0
SUPPL8Null0
SUPPL9Null0
SUPPL12Null7
SUPPL14Null15
SUPPL16Null15

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 71202
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.